Sort by
Refine Your Search
-
creativity, rigorous scholarship, and collaboration. You'll have opportunities to develop new skills, contribute to high-impact publications, and expand your professional growth while making meaningful
-
opportunity to lead innovative projects, collaborate with interdisciplinary researchers, and help advance our understanding of brain function. Minimum Requirements: Ph.D. in Neuroscience, Biomedical Engineering
-
to understanding the fundamental mechanisms that drive cancer development, treatment response, and therapeutic resistance. By combining cutting-edge molecular biology, functional genomics, and translational research
-
, and large-scale simulation. The successful candidate will contribute to the development of an HIV epidemic simulation that integrates dynamic social and sexual networks, heterogeneous susceptibility and
-
-derived brain and cardiac organoids. Successful candidates will have the opportunity to work in a collaborative and interdisciplinary environment that combines genomics technology development, stem cell and
-
. Postdoctoral Associate – Regenerative CAR T Therapy for Duchenne Muscular Dystrophy This Postdoctoral Associate will serve on a project focused on developing regenerative CAR T-based therapeutic strategies
-
-edge technologies, including genetically engineered mouse models, patient-derived models, single-cell and spatial genomics, organoid systems, and preclinical therapeutic studies. Learn more about our
-
international programs in more than 150 countries. The Pratt School of Engineering at Duke University is one of the fastest rising, highly ranked engineering schools in the nation. The school consists of four
-
position is ideal for a motivated scientist who wants to develop independent research questions, generate high-quality mechanistic and translational data, contribute to manuscripts and grants, and work
-
-epithelial interactions. The role employs a multi-modal research approach spanning genetically engineered mouse models, histopathology, mouse and human organoids, CRISPR-Cas9 gene editing, single-cell